Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$87.2 - $114.05 $2.25 Million - $2.94 Million
-25,749 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$94.19 - $124.49 $14,034 - $18,549
149 Added 0.58%
25,749 $2.86 Million
Q4 2021

Feb 04, 2022

SELL
$119.57 - $139.07 $57,632 - $67,031
-482 Reduced 1.85%
25,600 $3.28 Million
Q3 2021

Nov 12, 2021

SELL
$109.17 - $142.35 $82,314 - $107,331
-754 Reduced 2.81%
26,082 $3.47 Million
Q2 2021

Aug 13, 2021

SELL
$100.34 - $115.69 $2.6 Million - $3 Million
-25,932 Reduced 49.14%
26,836 $2.9 Million
Q1 2021

May 14, 2021

SELL
$101.51 - $125.27 $232,965 - $287,494
-2,295 Reduced 4.17%
52,768 $5.56 Million
Q4 2020

Feb 16, 2021

BUY
$85.88 - $105.36 $788,550 - $967,415
9,182 Added 20.01%
55,063 $5.73 Million
Q3 2020

Nov 04, 2020

BUY
$72.74 - $92.5 $2.27 Million - $2.89 Million
31,257 Added 213.74%
45,881 $3.93 Million
Q2 2020

Jul 31, 2020

SELL
$48.02 - $79.04 $5.54 Million - $9.12 Million
-115,426 Reduced 88.76%
14,624 $1.07 Million
Q1 2020

May 08, 2020

BUY
$36.95 - $62.95 $4.81 Million - $8.19 Million
130,050 New
130,050 $6.76 Million
Q4 2019

Feb 11, 2020

SELL
$47.06 - $56.64 $1.2 Million - $1.45 Million
-25,586 Closed
0 $0
Q3 2019

Nov 01, 2019

BUY
$47.45 - $58.05 $1.21 Million - $1.49 Million
25,586 New
25,586 $1.22 Million
Q2 2019

Aug 13, 2019

SELL
$39.26 - $54.21 $273,406 - $377,518
-6,964 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$29.84 - $43.92 $575,524 - $847,085
-19,287 Reduced 73.47%
6,964 $283,000
Q4 2018

Feb 14, 2019

BUY
$29.95 - $46.34 $786,217 - $1.22 Million
26,251 New
26,251 $819,000
Q3 2018

Nov 14, 2018

SELL
$40.12 - $45.55 $5.72 Million - $6.49 Million
-142,537 Closed
0 $0
Q2 2018

Aug 06, 2018

BUY
$38.72 - $42.52 $112,016 - $123,010
2,893 Added 2.07%
142,537 $5.97 Million
Q1 2018

May 03, 2018

BUY
$39.4 - $47.39 $5.5 Million - $6.62 Million
139,644 New
139,644 $5.73 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Mackay Shields LLC Portfolio

Follow Mackay Shields LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.